New hope for lymphoma patients at high risk of cancer returning
NCT ID NCT03463057
Summary
This study tests whether adding the immunotherapy drug atezolizumab after standard chemotherapy can help prevent cancer from returning in patients with high-risk diffuse large B-cell lymphoma. The trial enrolled 109 adults who had responded well to initial treatment but remain at high risk of relapse. Researchers want to see if this additional treatment improves survival by targeting any remaining cancer cells the initial therapy might have missed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DLBCL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BE-Antwerpen Edegem-UZA
Antwerp, Belgium
-
BE-Antwerpen-ZNASTUIVENBERG
Antwerp, Belgium
-
BE-Brugge-AZBRUGGE
Bruges, Belgium
-
BE-Leuven-UZLEUVEN
Leuven, Belgium
-
BE-Roeselare-AZDELTA
Roeselare, Belgium
-
NL-Amersfoort-MEANDERMC
Amersfoort, Netherlands
-
NL-Amsterdam-OLVG
Amsterdam, Netherlands
-
NL-Amsterdam-VUMC
Amsterdam, Netherlands
-
NL-Apeldoorn-GELREAPELDOORN
Apeldoorn, Netherlands
-
NL-Breda-AMPHIA
Breda, Netherlands
-
NL-Delft-RDGG
Delft, Netherlands
-
NL-Den Bosch-JBZ
's-Hertogenbosch, Netherlands
-
NL-Den Haag-HAGA
The Hague, Netherlands
-
NL-Dordrecht-ASZ
Dordrecht, Netherlands
-
NL-Ede-ZGV
Ede, Netherlands
-
NL-Eindhoven-CATHARINA
Eindhoven, Netherlands
-
NL-Eindhoven-MAXIMAMC
Eindhoven, Netherlands
-
NL-Enschede-MST
Enschede, Netherlands
-
NL-Groningen-UMCG
Groningen, Netherlands
-
NL-Hilversum-TERGOOI
Hilversum, Netherlands
-
NL-Hoofddorp-SPAARNEGASTHUIS
Hoofddorp, Netherlands
-
NL-Leeuwarden-MCL
Leeuwarden, Netherlands
-
NL-Leiden-LUMC
Leiden, Netherlands
-
NL-Maastricht-MUMC
Maastricht, Netherlands
-
NL-Nieuwegein-ANTONIUS
Nieuwegein, Netherlands
-
NL-Nijmegen-CWZ
Nijmegen, Netherlands
-
NL-Rotterdam-ERASMUSMC
Rotterdam, Netherlands
-
NL-Rotterdam-MAASSTADZIEKENHUIS
Rotterdam, Netherlands
-
NL-Sittard-Geleen-ZUYDERLAND
Sittard, Netherlands
-
NL-Tilburg-ETZ
Tilburg, Netherlands
-
NL-Utrecht-UMCUTRECHT
Utrecht, Netherlands
-
NL-Zwolle-ISALA
Zwolle, Netherlands
Conditions
Explore the condition pages connected to this study.